After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
United Therapeutics Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of United Therapeutics Corp is $11.29B. A total of 0.57 million shares were traded on the day, compared to an average of 390.44K shares.
In the most recent transaction, MAHON PAUL A sold 6,000 shares of UTHR for 237.38 per share on Mar 07 ’24. After the transaction, the EVP & GENERAL COUNSEL now owns 36,599 company shares. In a previous transaction on Mar 06 ’24, ROTHBLATT MARTINE A sold 15,000 shares at 236.25 per share. UTHR shares that CHAIRPERSON & CEO owns now total 130.
Among the insiders who sold shares, ROTHBLATT MARTINE A disposed of 6,300 shares on Mar 05 ’24 at a per-share price of $230.93. This resulted in the CHAIRPERSON & CEO holding 130 shares of UTHR after the transaction. In another insider transaction, PATUSKY CHRISTOPHER sold 1,680 shares at $224.00 per share on Feb 23 ’24. Company shares held by the Director now total 4.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, UTHR has a high of $261.54 and a low of $204.44.
As of this writing, UTHR has an earnings estimate of $5.64 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $6.53 per share and a lower estimate of $4.75. The company reported an EPS of $5.38 in the last quarter, which was 6.70% higher than expectations of $5.04.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. UTHR’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $800.00M in debt and $305.40M in liabilities at the time. Its Book Value Per Share was $127.23, while its Total Shareholder’s Equity was $3.96B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for UTHR is Buy with a score of 4.50.
